ASCO Highlights Seven of 4,000 Abstracts Submitted for Annual Meeting, June 3-7
Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds
Targeting One Specific Protein Can Double PFS; Triple Overall Survival
Revlimid Maintenance Therapy Delayed Progression by 90%
Drug Effectiveness Weakens After Three Years, Study Says
Nexavar Improves PFS In HER-2 Negative Breast Cancer
Xgeva Significantly Increases Bone Metastasis-Free Survival
U.S. Patients Use More Chemotherapy, Less Emergency Care than Canadians
Urocidin May Provide Alternative To Cystectomy in BCG Cancers
Clinical Trials Approved By NCI CTEP Last Month
Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors
Abbott PCR Test For HCV Load Sensitive to Within 12 IU/mL
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final
